|
Defensibility
Q. How do I know that the systems and processes
used by Altrix are defensible?
A. The chain of custody procedures
employed by Altrix are very robust and stringent. The microplate
assays used in the laboratory have approval
for drugs of screening, and the screening and confirmation methods have been externally audited by UKAS as part of the ISO 17025:2005 standard.
Below is a document prepared by John Grace QC who is one of the
UK’s leading legal experts on the defensibility of drug testing.
This will give you an idea of the issues surrounding the defensibility
of drug testing. Hopefully, the report will answer your questions
on whether the systems and processes used by Altrix Healthcare are
defensible. If you have any other questions, or would like to receive
a CD of Mr John Grace QC presenting this paper, please contact Altrix.
Expert witness in the format of both written report and personal
appearance are part of the Altrix service provision to our customers.
|
 |